1. Home
  2. VIGL vs PRPL Comparison

VIGL vs PRPL Comparison

Compare VIGL & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIGL
  • PRPL
  • Stock Information
  • Founded
  • VIGL 2020
  • PRPL 2010
  • Country
  • VIGL United States
  • PRPL United States
  • Employees
  • VIGL N/A
  • PRPL N/A
  • Industry
  • VIGL Biotechnology: Pharmaceutical Preparations
  • PRPL Home Furnishings
  • Sector
  • VIGL Health Care
  • PRPL Consumer Discretionary
  • Exchange
  • VIGL Nasdaq
  • PRPL Nasdaq
  • Market Cap
  • VIGL 89.3M
  • PRPL 90.3M
  • IPO Year
  • VIGL 2022
  • PRPL N/A
  • Fundamental
  • Price
  • VIGL $2.76
  • PRPL $1.04
  • Analyst Decision
  • VIGL Strong Buy
  • PRPL Buy
  • Analyst Count
  • VIGL 5
  • PRPL 3
  • Target Price
  • VIGL $21.00
  • PRPL $1.70
  • AVG Volume (30 Days)
  • VIGL 2.7M
  • PRPL 561.8K
  • Earning Date
  • VIGL 03-25-2025
  • PRPL 03-11-2025
  • Dividend Yield
  • VIGL N/A
  • PRPL N/A
  • EPS Growth
  • VIGL N/A
  • PRPL N/A
  • EPS
  • VIGL N/A
  • PRPL N/A
  • Revenue
  • VIGL N/A
  • PRPL $504,838,000.00
  • Revenue This Year
  • VIGL N/A
  • PRPL N/A
  • Revenue Next Year
  • VIGL N/A
  • PRPL $1.83
  • P/E Ratio
  • VIGL N/A
  • PRPL N/A
  • Revenue Growth
  • VIGL N/A
  • PRPL N/A
  • 52 Week Low
  • VIGL $1.49
  • PRPL $0.75
  • 52 Week High
  • VIGL $6.06
  • PRPL $2.33
  • Technical
  • Relative Strength Index (RSI)
  • VIGL 70.15
  • PRPL 50.04
  • Support Level
  • VIGL $2.54
  • PRPL $0.99
  • Resistance Level
  • VIGL $2.88
  • PRPL $1.09
  • Average True Range (ATR)
  • VIGL 0.22
  • PRPL 0.08
  • MACD
  • VIGL 0.03
  • PRPL -0.02
  • Stochastic Oscillator
  • VIGL 85.19
  • PRPL 23.64

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

Share on Social Networks: